Drug
Eplerenone Sandoz Inc
Eplerenone Sandoz Inc: highest development phase Phase 1, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Eplerenone 50 mg Tablets Sandoz Inc., USA NCT00865176 | Phase 1 | Hypertension |
Latest
No recent events.
Follow Eplerenone Sandoz Inc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.